A study recently published in Translational Psychiatry, a Nature journal, has shown how using cultured cells from patients with psychotic disorders, such as schizophrenia, to investigate abnormalities in nerve connections in the brain could lead to new treatments. Strong correlations were observed between the findings in the cells in culture—grown outside the body in a controlled environment—and findings from brain imaging performed on the same human participants.
“The findings are important, because if the health of cells in culture reflects the health of the same cells in a human brain, we may be able to create a better model for studying psychotic disorders,” said the study’s senior author, Bruce M. Cohen, MD, PhD, director of McLean Hospital’s Program for Neuropsychiatric Research (PNPR). Cohen said such a model could give researchers a greater capacity to find genetic and biochemical targets in the brain. Using these targets, he said, “could enable us to develop novel and more effective interventions for psychotic disorders.”
For their work, Cohen and his colleagues, including first author Donna L. McPhie, PhD, director of the Cellular Neuropsychiatry Laboratory in the PNPR, drew on studies showing that altered pathways of brain development can be found across most cases of schizophrenia and that inaccurate connections and “leaks” in signaling between nerve cells are a feature of many psychotic disorders. A substance called myelin, produced by cells called oligodendrocytes, serves as a kind of insulation to prevent these leaks. In studies at McLean Hospital by co-author Dost Öngür, MD, PhD, chief of the Psychotic Disorders Division at McLean, and his colleagues, myelin was measured and found to be reduced in the brain in patients with schizophrenias.
Based on this prior research, Cohen and his colleagues drew on a repository of cell lines they had obtained from patients with psychiatric disorders. These samples were reprogrammed from skin cells into brain-like cells in the laboratory. The reprogrammed cell lines, taken from both ill and healthy patients, produced nerve cells and support cells called glia, including oligodendrocytes, in laboratory cultures. Investigations into these cells revealed significant abnormalities in the development of oligodendrocytes grown from subjects with psychotic disorders.
The research also revealed a strong correlation between the number of oligodendrocytes in culture and the amount of myelin made by these cells in the brains of the same subjects who provided the cells. This finding, Cohen explained, “means that we can now study the causes of the abnormality of myelin that we have observed in living brain tissue in a laboratory setting.”
For Cohen and his colleagues, the prospect of using lab cultures to examine differences in the brains of individuals with psychotic illnesses is “an exciting development.” For example, Cohen said, researchers have observed that not all genes and proteins necessary to make oligodendrocytes are affected in these cells, and they can now begin to identify exactly what genes and proteins are different in these cells. It would be impossible, he said, to do these detailed studies in living brain tissue.
Such studies, the researchers believe, could lead to better treatment approaches for individuals with psychotic conditions. “Using in vitro cell cultures to study these abnormalities could help us identify specific genetic and biochemical targets that might be addressed by novel drug treatments, cell transplantation, or other interventions,” Cohen said.
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
Levels of gene-expression-regulating enzyme altered in brains of people with schizophrenia
on December 14, 2018 at 12:15 pm
Using the PET scan tracer Martinostat, Mass. General Hospital investigators found that expression of HDAC epigenetic enzymes (red) is higher in a brain region (arrows) known to be important for ... […]
on December 14, 2018 at 11:52 am
Schizophrenia affects about 1% of the world’s population and is one of the most feared and misunderstood mental health health problems that a person can experience. Images of psychiatric hospitals, se... […]
Genomic data from 2000 human brains could reveal roots of schizophrenia, autism, and other neurological disorders
on December 13, 2018 at 2:03 pm
More than 2000 human brains stored in tissue banks are giving up their genetic secrets. Genome scans have already revealed hundreds of locations where DNA tends to differ between people with and witho... […]
Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
on December 13, 2018 at 6:06 am
Sunovion Pharmaceuticals and PsychoGenics unveiled positive phase 2 results for a new schizophrenia treatment that does not bind to the brain’s dopamine receptors. While its exact mechanism of action ... […]
Vitamin D and Schizophrenia; 007 and Alcohol Abuse
on December 12, 2018 at 2:49 pm
Newborns with vitamin D deficiency may face higher risk for schizophrenia later in life, a Danish case-control study indicated. "The next step is to conduct randomized clinical trials of vitamin D sup... […]
The NIMH Research Domain Criteria Initiative and Comorbidity in Schizophrenia: Research Implications
on December 12, 2018 at 11:10 am
A particular challenge to traditional diagnostic classifications is psychiatric comorbid presentations. In the case of schizophrenia, the DSM-5 considers comorbid symptoms as part of another diagnosis ... […]
FDA to Review Lumateperone for Treatment of Schizophrenia
on December 11, 2018 at 1:30 pm
Intra-Cellular Therapies announced that the Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for lumateperone (ITI-007) for the treatment of schizophrenia. Lum... […]
What to Know About Schizophrenia—a Chronic, Misunderstood Mental Illness
on December 11, 2018 at 9:46 am
Schizophrenia is a serious mental illness that alters how a person feels, what they see, and how they behave. It’s a chronic condition, and there's no cure for it. However, many people with schizophre... […]
Study: Newborns with Vitamin D Deficiency Have Higher Risk of Later Schizophrenia
on December 11, 2018 at 4:32 am
A study published in the December 6, 2018 issue of the journal Scientific Reports found newborns with vitamin D deficiency had a 44% increased risk of being diagnosed with schizophrenia as adults comp... […]
via Bing News